Overview Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis Status: NOT_YET_RECRUITING Trial end date: 2028-10-01 Target enrollment: Participant gender: Summary Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral SclerosisPhase: PHASE2 Details Lead Sponsor: Zydus Therapeutics Inc.